Abera Bioscience AB (publ) (NGM:ABERA)
6.86
+0.10 (1.48%)
At close: Sep 30, 2026
Abera Bioscience AB Market Cap
Abera Bioscience AB has a market cap or net worth of 140.62 million as of November 18, 2026. It is the 39,136th most valuable company in the world and the 548th biggest in Sweden. Its market cap has increased by 36.71% in one year.
Market Cap
140.62M
Enterprise Value
122.91M
Revenue
9.10M
Global Rank
Country Rank
#548 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since February 24, 2021, Abera Bioscience AB's market cap has increased from 115.59M to 140.62M, an increase of 21.66%. That is a compound annual growth rate of 3.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 140.62M | 12.10% |
| Dec 30, 2025 | 125.44M | 81.17% |
| Dec 30, 2024 | 69.24M | -7.23% |
| Dec 29, 2023 | 74.63M | 20.46% |
| Dec 30, 2022 | 61.96M | -64.21% |
| Dec 30, 2021 | 173.12M | 49.77% |
| Feb 24, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xbrane Biopharma AB | 230.78M |
| BioInvent International AB | 178.66M |
| Initiator Pharma | 167.71M |
| Elicera Therapeutics AB | 161.17M |
| Diamyd Medical AB | 139.95M |
| Xintela AB | 120.58M |
| Simris Group AB (PUBL) | 119.87M |
| IRLAB Therapeutics AB | 118.37M |